{"id":2620,"date":"2026-09-23T12:07:01","date_gmt":"2026-09-23T12:07:01","guid":{"rendered":"https:\/\/nhdbio.com\/?p=2620"},"modified":"2026-09-23T12:07:01","modified_gmt":"2026-09-23T12:07:01","slug":"curvas-do-ensaio-de-adsorcao-por-diluicao-em-serie-de-peptideos","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/peptide-serial-dilution-adsorption-assay-curves\/","title":{"rendered":"Dilui\u00e7\u00e3o seriada de pept\u00eddeos: por que a curva planejada pode diferir das concentra\u00e7\u00f5es dispensadas"},"content":{"rendered":"

A serial dilution calculator can produce exact nominal concentrations while the assay wells receive something else. Peptides can contact tips, reservoirs and plates, and incomplete mixing can propagate error through a dilution chain. For a concentration-response experiment, the relevant question is whether the delivered concentration series<\/strong> is sufficiently close to the planned one for the scientific decision.<\/p>\n

A published peptide assay workflow<\/h2>\n

Naylor and colleagues described a non-contact acoustic-dispensing workflow for peptide agonists measured in a mouse GLP-1 receptor cell assay. Their protocol prepared intermediate peptide stocks and then a concentration series in acoustically qualified microplates. In the published example, a 384-well plate<\/strong> held an 11-point concentration range for 16 peptides in duplicate<\/strong>; transfer to the assay plate used a constant 100 nL per well<\/strong>. The procedure also used backfill and centrifugation to mix intermediate solutions. These are protocol and demonstration dimensions<\/strong>, not recovery percentages or an estimate that every peptide retains potency. [1, Protocol; Figures 1\u20132]<\/p>\n\n\n\n\n\n\n\n\n
Published design element<\/th>\nReported setting<\/th>\nWhy it matters<\/th>\n<\/tr>\n<\/thead>\n
Assay plate<\/td>\n384 wells<\/td>\nLayout, edge effects and available controls need planning.<\/td>\n<\/tr>\n
Concentration range<\/td>\n11 points<\/td>\nA curve needs coverage above and below its transition region.<\/td>\n<\/tr>\n
Example analytes<\/td>\n16 peptides in duplicate<\/td>\nReplicate positions permit an initial reproducibility check.<\/td>\n<\/tr>\n
Final acoustic transfer<\/td>\n100 nL per well<\/td>\nSmall transfer demands qualified source plates and instrument verification.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

The authors’ motivation was to reduce sample contact with plastic tips. That is a plausible control for adsorption, but an acoustic transfer can introduce its own requirements for source-plate geometry, fluid properties and mixing. Their report is a protocol paper, not a universal head-to-head recovery study for all peptide chemistries. [1]<\/p>\n

Validate the delivered series<\/h2>\n

Begin with the serial dilution planner<\/a> to record intended concentrations and volumes. Then separate three checks: calculation<\/strong>, liquid transfer<\/strong>, and biological\/analytical readout<\/strong>. Recalculate the series independently; verify delivered volume with a suitable gravimetric or dye method where possible; and assess a peptide-specific control series with replicates across the plate. For a tip-based process, fresh tips and controlled prewetting may matter. For an acoustic process, check fluid compatibility and mixing after backfill. Neither approach fixes a wrongly assigned stock concentration.<\/p>\n

If the apparent potency changes when only the dispensing method changes, do not immediately infer a change in receptor pharmacology. Recheck concentration assignment, surfaces, matrix additives, final solvent fraction, plate position and assay timing. Some additives used to reduce adsorption may alter the assay itself, so each requires a control. The complete trail from stock to well should remain available alongside the final fitted curve.<\/p>\n

An earlier separate experimental report<\/strong> by Naylor and colleagues compared acoustic and tip-based preparation for GLP-1 and glucagon peptide analogues and reported changes in apparent potency curves with handling method. Its publisher abstract supports that direction of concern but provides no transferable effect size; no numerical acoustic benefit is claimed here. [2] The later protocol also states that its automated series used less than 1 \u00b5L of sample<\/strong> across a nominal 3 \u00d7 10\u2076 concentration range<\/strong>. Those are workflow dimensions, not evidence that the delivered concentrations were correct in another laboratory. [1, Discussion]<\/p>\n

Before accepting a fitted curve<\/h3>\n